Find uplifting stories about heroes, innovations, and solutions
19123 results for "alzheimer's research"
After decades of research, two FDA-approved medications can now slow Alzheimer's progression by up to 30%, and blood tests can detect the disease 15 to 20 years before symptoms appear. Scientists gathered in San Diego to share breakthrough findings that are transforming how we fight dementia.
For the first time in history, medications can actually slow Alzheimer's progression, not just mask symptoms. While the effects are modest, they've sparked an explosion of clinical trials that researchers say marks a turning point in defeating the disease.
A scientist who revolutionized protein research is now tackling science's reproducibility crisis with AI. His new approach could help researchers separate reliable studies from questionable ones, speeding up cures for diseases like Alzheimer's.
Scientists discovered that combining natural molecules from grapes and turmeric with existing drugs treats Alzheimer's more safely and effectively. This breakthrough could help nearly a million Canadians expected to have dementia by 2030.
Scientists in South Korea discovered a protein that could tackle multiple causes of Alzheimer's at once, reversing symptoms in mice and pointing to a completely new treatment approach. The breakthrough offers hope for millions as current drugs only address part of the disease.
University of Miami scientists found a way to restore blood flow in the brains of mice with Alzheimer's, a breakthrough that could lead to new treatments for the 7 million Americans living with the disease. By activating a specific protein in blood vessels, they reversed one of the earliest warning signs of the condition.
A Cambridge biotech just secured $5 million to fast-track a groundbreaking Alzheimer's treatment that targets brain inflammation instead of protein buildup. The therapy could help millions by addressing a root cause that's been overlooked for decades.
University of Utah researchers discovered how toxic proteins travel between brain cells in Alzheimer's disease, potentially opening the door to treatments that could slow the condition's progression. The key culprit is a common brain protein that accidentally helps disease spread from sick neurons to healthy ones.
Families carrying rare Alzheimer's genes are volunteering for groundbreaking research that's helped develop new treatments. Their network faces uncertainty as federal funding stalls.
Researchers discovered how two key brain proteins might work together to trigger Alzheimer's disease, potentially explaining decades of conflicting research. This breakthrough could redirect treatment efforts toward protecting brain cells rather than just clearing protein buildup.
A groundbreaking study of over 21,000 patient records reveals that women taking estrogen-only hormone therapy showed fewer signs of dementia and Alzheimer's disease. The research offers new hope for understanding why two-thirds of Alzheimer's patients are women.
Vanderbilt researchers developed two breakthrough compounds that let scientists study TAOK proteins for the first time, opening new paths to understanding and potentially treating Alzheimer's disease. More than seven million Americans with Alzheimer's now have new hope for future treatments.
New research links blood sugar spikes after meals to Alzheimer's disease risk, offering hope that simple diet changes could protect brain health. Scientists found genetic predisposition to post-meal sugar spikes increased relative Alzheimer's risk by 69 percent.
New research confirms Maria Shriver's decades-old hunch: women represent two-thirds of Alzheimer's diagnoses, but scientists now say nearly half of all cases can be prevented. After her father's diagnosis, Shriver founded the Women's Alzheimer's Movement and is empowering people to take charge of their brain health early.
Scientists are discovering unexpected connections between autism and Alzheimer's disease that could revolutionize how we understand and treat both conditions. What started as implausible hints in medical literature has become a promising new avenue of research.
Researchers discovered a molecular switch that drives harmful brain inflammation in Alzheimer's disease, and turning it off protected brain connections in mice. The finding could lead to new treatments that calm overactive immune responses without blocking normal defenses.
Researchers discovered how to turn off a molecular trigger that fuels damaging brain inflammation in Alzheimer's disease. The breakthrough could lead to treatments that protect memory without weakening the immune system.
French researchers discovered specialized brain cells that act as highways to clear toxic proteins linked to Alzheimer's disease. In people with the disease, these cells malfunction, offering a new explanation for how damaging proteins accumulate in the brain.
Researchers discovered a toxic protein pair that kills brain cells in Alzheimer's and used a new drug to stop it in mice, slowing memory loss. The breakthrough targets a different pathway than previous treatments, offering fresh hope for millions.
Scientists discovered that a natural compound in aloe vera may help slow the enzymes linked to memory loss in Alzheimer's disease. While still early research, the plant-based molecule shows strong potential for future drug development.
Showing 20 of 19123